Mochida Pharmaceutical Co., Ltd.

TSE:4534.T

3280 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q3
Operating Activities:
Net Income 1,5541031,6061,1501,688-1,4324,1587683,1553895,2642,2632,6531802,9962,0443,367-1,7801,7861,2873,305-1,4142,9131,0935,843-2473,3481,6044,318-1,2694,2332,2873,275-2483,5831,6163,1991,0513,3961,1771,9201,3884,1002,4641,9401,6672,3332,478-2,6884,5362,7283,5791,7664,4735,2684,2761,6934,907
Depreciation & Amortization 007286656436986896680000000000000000000000000000000000000000814761663628776753666633750678
Deferred Income Tax 0000000000000000000000000000000000000000000000000000000000
Stock Based Compensation 0000000000000000000000000000000000000000000000000000000000
Change In Working Capital 000-3,478.500000000000000000000000000000000000000000000841-808-2,7341,3352,429-1,673-2,9312,6191,488-1,424
Accounts Receivables 000-1,730.5000000000000000000000000000000000000000000000000000000
Change In Inventory 000-1,74800000000000000000000000000000000000000000000740383233-499-16902-54-32-37641
Change In Accounts Payables 0000000000000000000000000000000000000000000000000000000000
Other Working Capital 000000000000000000000000000000000000000000000000101-1,191-2,9671,8342,445-2,575-2,8772,6511,864-1,465
Other Non Cash Items -1,554-103-1,606-1,150-1,6881,432-4,158-768-3,155-389-5,264-2,263-2,653-180-2,996-2,044-3,3671,780-1,786-1,287-3,3051,414-2,913-1,093-5,843247-3,348-1,604-4,3181,269-4,233-2,287-3,275248-3,583-1,616-3,199-1,051-3,396-1,177-1,920-1,388-4,100-2,464-1,940-1,667-2,333-2,4784,051-3,4041,532-4,7731,265-2,929127-5,301531-2,525
Operating Cash Flow 001,456-2,9651,2861,3961,3781,33600000000000000000000000000000000000000003,0181,0852,1897696,2366243,1302,2274,4621,636
Investing Activities:
Investments In Property Plant And Equipment 000-860.500000000000000000000000000000000000000000000-1,288-48-814-308-624-61-518-698-1,403-425
Acquisitions Net 0000000000000000000000000000000000000000000000000000000000
Purchases Of Investments 0000000000000000000000000000000000000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000000000000000000000000000000000000
Other Investing Activites 000-34.500000000000000000000000000000000000000000000397224-1024802-197668-10-3-148
Investing Cash Flow 000-89500000000000000000000000000000000000000000000-891176-916-304178-258150-708-1,406-573
Financing Activities:
Debt Repayment 00000000000000000000000000000000000000000000000000-1,5000-3000-3000-3000
Common Stock Issued 000000000000000000000000000000000000000000000000857151529000
Common Stock Repurchased 000-1,46500000000000000000000000000000000000000000000-1,652-892-871-6-2,246-22-34-11-1,143-1,662
Dividends Paid 000000000000000000000000000000000000000000000000-5-1,218-2-1,564-6-1,261-4-1,372-5-1,172
Other Financing Activities 000-1,468.500000000000000000000000000000000000000000000-11-111,491-10-10-7-308-9-2-2
Financing Cash Flow 000-2,199.500000000000000000000000000000000000000000000-1,650-2,116629-1,579-2,545-1,275-309-1,392-1,440-2,836
Other Information:
Effect Of Forex Changes On Cash 00033.5000000000000000000000000000000000000000000000000000000
Net Change In Cash 00-4,848-20,75631,003-35,13518,842-22,0930000000000000000000000000000000000000000476-8531,901-1,1153,870-9112,9711271,616-1,773
Cash At End Of Period 0029,90934,75755,51324,51059,64540,803000000000000000000000000000000000000000026,84326,36727,22025,31926,43422,56423,47520,50420,37718,761